(reviewed by Morgan and Suematsu, 1990; Somlyo and Somlyo, 1994; Kamm and Stull, 2001 ). Excitatory receptor agonists also exert inhibitory regulation on the MLC de-phosphorylating enzyme, myosin light chain phosphatase (MLCP), which acts to potentiate Ca
2+
-induced MLC phosphorylation and contraction (reviewed by Somlyo and Somlyo, 2003; Pfitzer, 2001; Sward et al., 2003; Takuwa et al., 2005) .
Accumulating evidence implicates the small GTPase Rho and the Rho effector
Rho-kinase in the negative regulation of MLCP by excitatory receptor agonists; excitatory receptor agonists trigger Rho activation (Sakurada et al., 2001 ), leading to MLCP inhibition through mechanisms involving Rho kinase-dependent phosphorylation of the 110-kDa myosin targeting subunit MYPT1/MBS of MLCP at Thr 695 and/or Thr 850 (numbering of chicken M133 isoform) (Noda et al., 1995; Kimura et al., 1996;  This article has not been copyedited and formatted. The final version may differ from this version. 5 Hartshorne et al., 2004) and also of the smooth muscle-specific MLCP inhibitor protein, CPI-17 (Kitazawa et al., 2000; Niiro et al., 2003) . CPI-17 may also be phosphorylated by a protein kinase C-dependent mechanism (Eto et al., 2001) . Thus, Rho acts as a switch molecule to negatively regulate MLCP in smooth muscle.
MOL#32599
We and others demonstrated that membrane depolarization and ionomycin induce Rho activation and MLCP inhibition in a Ca 2+ -dependent manner in vascular smooth muscle (Mita et al., 2002; Sakurada et al., 2003; Sakamoto et al., 2003; Wang et al., 2006 
6 and MYPT1 phosphorylation as well as MLC phosphorylation and contraction (Wang et al., 2006) , suggesting that a PI3K plays a critical role in the activation of the Rho signaling pathway. We showed evidence that class II PI3K enzyme PI3K-C2α, which characteristically exhibits relatively lower sensitivities to PI3K inhibitors compared with other isoforms (Domin et al., 1997; Stein and Water field, 2000) , is a PI3K isoform that is responsible for the receptor agonist noradrenaline-induced, PI3K 
Differentiated VSMC culture and contraction measurement
Rat aortic VSMCs were isolated from 5-week-old rat aortae by an enzyme-dispersion method as essentially described (Hayashi et al., 2001) . Briefly, aortae were dissected under sterile conditions, and incubated at 37°C in 0.1% collagenase (Type V, Sigma) and 0.05% elastase (Type III, Sigma) for 30 min, followed by further incubation in the mixtures for 45 min after separating adventitia from aortic rings. Dispersed single cells were separated from undigested tissues by filtration, and were collected by centrifugation. The cells thus obtained were cultured in the serum-free medium containing IGF-I (2 ng/ml) on laminin (20 µg/mL in PBS)-coated glass bottom LabTek chamber slides (Nunc) for 3 days after isolation.
Ionomycin-and ligand-induced contractility of VSMCs was monitored as follows (Wang et al, 2006 F-127/2mM probenecid for 45 min at 37°C. Cells were washed 3 times for 30 min using BSS containing 2 mM probenecid and viewed using the laser confocal microscope with excitation at 488 nm light and fluorescence detection at 510 nm, and images were captured every 500 ms with an EM-CCD cooled charge-coupled devise camera (iXon, Andor, UK). Pixel density was calculated from whole cell averages using the iXon iQ software (Andor). Temperature was maintained at 37 °C for the duration of the experiments with the Olympus microscopic incubator system (Olympus, Tokyo, Japan).
Synthesis and transfection of siRNA
This article has not been copyedited and formatted. The final version may differ from this version. Single-stranded, rat PI3K-C2α-specific sense and anti-sense RNA oligonucleotides, and control scrambled oligonucleotide were synthesized by in vitro transcription using the Silencer siRNA construction kit (Ambion, Austin, TX) and annealed to generate a RNA duplex, as described in detail previously (Usui et al., 2004) . The target sequences of PI3K-C2α-specific siRNA#1, PI3K-C2α-specific siRNA#2, p110α-specific siRNA, and scrambled RNA duplex were 5'-AAGATATTGCTGGATGACAAT-3',
and 5'-AATCGACTGTGATACTACAAT -3', respectively. The cells were transfected with short interfering RNA (siRNA) (20 nM) using Lipofectamine 2000 with pEGF-C1 48 h before experiments. At least 60 % of VSMCs were found to be transfected under our experimental condition, as evaluated by using fluorescent GAPDH-specific siRNA (Ambion).
Determination of phosphorylation of MLC, and MYPT1
The VSMCs were quickly rinsed once with ice-cold Ca
2+
, Mg 2+ -free Dulbecco's phosphate buffered saline (PBS) and fixed with ice-cold stop buffer containing 10%
This article has not been copyedited and formatted. The final version may differ from this version. 
RESULTS

Knockdown of PI3K-C2α by siRNA inhibits ionomycin-induced contraction
Transfection of VSMCs with either PI3K-C2α-specific siRNA #1 (C2α-siRNA#1)
or PI3K-C2α-specific siRNA #2 (C2α-siRNA#2) induced a marked reduction in the expression of PI3K-C2α protein (approximately 90 % decrease), but not class I PI3K isoform p110α, MLCK or smooth muscle-specific α-actin (αSMA), compared with the scrambled RNA counterpart (sc-siRNA) (Fig. 1A) . On the other hand, transfection with PI3K p110α-specific siRNA (p110α-siRNA) strongly inhibited the p110α protein expression but not PI3K-C2α expression. Thus, the effects of C2α-siRNA's were specific.
We employed the Ca 2+ ionophore ionomycin to induce Ca ]i response was not changed by PI3K-C2α knockdown (Fig. 1B) . To evaluate ionomycin-induced contractile responses more quantitatively, the VSMCs were transfected with an EGFP expression vector and observed under a fluorescence laser confocal microscope, which allowed for the accurate determination of a contractile response as described in the "Materials and
Methods". The addition of ionomycin (1 µM) induced a gradual decrease in the planar surface area of the VSMCs due to their contraction ( Fig. 1C and supplementary Fig. 2 for a movie). Contraction was detected within 1 min and reached a nearly maximal extent at 10 min. Certain cells became much more quickly shortened as they were detached from the substrate at one end due to the generation of a strong tension.
Quantitative analysis showed that ionomycin induced dose-dependent decreases in the planar surface area ( A/A 0 ) with a maximal 50 % decrease by 1 µM ionomycin in sc-siRNA-treated VSMCs (Fig. 1D) . Knockdown of PI3K-C2α expression by either C2α-siRNA#1 or C2α-siRNA#2 substantially (approximately 35-45%) inhibited ionomycin-induced contraction (see supplementary Fig. 3 for a movie) . In contrast, p110α-siRNA did not affect ionomycin-induced contraction (supplementary Fig. 4 for a This article has not been copyedited and formatted. The final version may differ from this version. (Domin et al., 1997; Wang et al., 2006) . Consistent with the notion that PI3K-C2α is involved in Ca
2+
-mediated contraction, a high (100 µM), but not low (10 µM), concentration of LY294002 inhibited ionomycin-induced contraction (Fig. 1E ).
These observations indicate that ionomycin-induced, Ca 2+ -mediated contraction is dependent on PI3K-C2α. (Fig. 3A) . Consistent with the inhibition of ionomycin-induced contraction by PI3K-C2α knockdown, either C2α-siRNA#1 or C2α-siRNA#2 abolished ionomycin-induced MYPT1 phosphorylation (Fig. 3A) . Similarly, the addition of Y27632 abolished ionomycin-induced MYPT1 phosphorylation at Thr 850 (Fig. 3B ). Y27632 also reduced the basal level of MYPT1 phosphorylation. Ionomycin induced several fold increases in mono-and di-phosphorylation of MLC (Fig. 3C) . The siRNA-mediated PI3K-C2α knockdown inhibited ionomycin-induced mono-and di-phosphorylation of MLC. These observations suggest that PI3K-C2α participates in Ca 2+ -induced contraction by regulating MLC phosphorylation through the mechanism involving Rho kinase-dependent phosphorylation of MLCP.
The expression of a dominant negative
Noradrenaline-induced contraction and phosphorylation of MYPT1 and MLC are
This article has not been copyedited and formatted. The final version may differ from this version. ]i followed by a lower sustained increase, with a robust contractile response ( The physiological function of class II member PI3K-C2α was not well understood.
PI3K-C2α uniquely exhibits lower sensitivities to two structurally different PI3K
inhibitors LY294002 and wortmannin, compared with the seven other PI3K isoforms (Domin et al., 1997; Stein and Waterfield, 2000) . Our observations (Wang et al., 2006) that membrane depolarization-induced, Ca
2+
-dependent Rho activation, phosphorylation of MLC and MYPT1, and contraction were all relatively less sensitive to the PI3K inhibitors than Akt phosphorylation which is a well-known downstream signaling event of class I PI3K enzymes (Franke et al., 1995) , led us to the hypothesis that PI3K-C2α might be involved in Ca for PI3K-C2α, as class I p110α-specific siRNA was ineffective. In agreement with the present data obtained by using siRNA-mediated PI3K-C2α and also our previous results in vascular smooth muscle tissues (Wang et al., 2006) , a lower concentration (10 µM) of LY294002, which can effectively inhibit various effects mediated by other PI3K
isoforms than PI3K-C2α (including Akt phosphorylation, cell migration and cell survival and proliferation) (Franke et al., 1995; King et al., 1997) , failed to inhibit the In addition to PI3K-C2α, vascular smooth muscle expresses at least three other PI3K members, class I enzymes p110α and p110β, and class II enzyme PI3K-C2β
This article has not been copyedited and formatted. The final version may differ from this version. (Fulton et al., 1999) , thus indirectly regulating vascular smooth muscle tone through the control of nitric oxide production. In addition, class I PI3K p110δ and PI3Kγ were suggested to be involved in enhanced spontaneous tone and reactive oxygen species-mediated, Akt-dependent stimulation of Ca 2+ entry, respectively, in some blood vessels from animals (Northcott et al., 2002; Vecchione et al., 2005) .
Unlike PI3K-C2α, both PI3K p110δ and PI3Kγ are well sensitive to relatively lower concentrations of PI3K inhibitors (Stein and Waterfield, 2000) , and indeed low concentrations of PI3K inhibitors suppressed these vascular effects mediated by p110δ
and PI3Kγ. Therefore, it is possible that more than a single PI3K isoforms could participate in vascular smooth muscle contraction through different mechanisms and This article has not been copyedited and formatted. The final version may differ from this version. that there might be a species-dependent difference in the PI3K-dependent mechanisms.
The receptor agonist noradrenaline induces Rho activation in vascular smooth muscle (Sakurada et al., 2001) . The α 1 adrenergic receptor for noradrenaline is a major adrenergic receptor subtype expressed in vascular smooth muscle. Noradrenaline induces a robust increase in the [Ca 2+ ]i via the α 1 receptor coupling to G q in vascular smooth muscle (Takuwa and Rasmussen, 1987) . In the present study Ca 2+ depletion with BAPTA-AM suppressed noradrenaline-induced, Rho kinase-dependent MYPT1 phosphorylation as well as contraction (Fig. 4) . Moreover, noradrenaline-induced MLC and MYPT1 phosphorylation was suppressed by PI3K-C2α knockdown (Fig. 5) . We also found previously that the PI3K inhibitors efficiently suppressed noradrenaline-induced Rho activation, phosphorylation of MYPT1 and MLC, and contracton in isolated arterial smooth muscle tissues (Wang et al., 2006) . Taken together, these observations suggest that noradrenaline induces Rho activation and MYPT1 phosphorylation in a Ca
-and PI3K-C2α-dependent manner, although the G 12/13 -dependent mechanism was also suggested to contribute to adrenergic receptor-mediated Rho stimulation (Gohla et al., 2000; Maruyama et al., 2002) . Thus, This article has not been copyedited and formatted. The final version may differ from this version. In the present study, we employed the VSMC culture on the laminin-coated substrate in the serum-free, chemically defined medium to evaluate contractile responses and their sensitivity to inhibitors. Generally, the culture of VSMCs in the presence of bovine serum after their isolation from blood vessels induces cell proliferation, which is accompanied by de-differentiation of VSMCs including downregulation of expression levels of contractile proteins and cell surface receptors, resulting in loss of contractility (Cambell and Cambell, 1993) . The VSMCs employed in the present study maintains high levels of protein expression of smooth muscle-specific α-actin and MLCK, and contractility (Hayashi et al., 2001) . This VSMC culture is also sensitive to gene transduction to a reasonable extent (see "Experimental procedures"). 
